Sen-Jam Pharmaceutical is revolutionizing hangover relief with their groundbreaking hangover prevention product, SJP-001. With over 2 billion people worldwide consuming alcohol and a projected $4.69 billion global hangover cure market by 2028, SJP-001 aims to be the first FDA-approved product in this space. Sen-Jam Pharmaceutical is focused on setting a new standard in the hangover prevention market by leveraging scientific research and evidence-based solutions.